EFTUD2 is known to be a modulator of the innate immune system: in colorectal cancer, EFTUD2 seems to promote tumor growth, especially in a colitis-associated environment and by modulation of macrophages (Lv et al. 2019). The gene discussed is EFTUD2; the disease is colitis.